TCDA News and Press, Tricida Inc. From 12/07/21

Gainers: Stitch Fix  (NASDAQ:SFIX) +2%. Fate Therapeutics (NASDAQ:FATE) +2%. Frequency Therapeutics (NASDAQ:FREQ) +1%. Criteo  (NASDAQ:CRTO) +1%. EVgo  (NASDAQ:EVGO) +1%. Losers: Nexters  (NASDAQ:GDEV) -3%. Ocular Therapeutix (NASDAQ:OCUL) -2%. Sig...

Shares of Tricida (NASDAQ: TCDA) were jumping 11% higher as of 11:23 a.m. EST on Tuesday. The solid gain came after the company announced that it had entered into definitive agreements to sell stock and warrants that will generate gross proceeds of around $42 million. It's par f...

SOUTH SAN FRANCISCO, Calif., Nov. 15, 2021 (GLOBE NEWSWIRE) -- Tricida, Inc. (Nasdaq: TCDA), a pharmaceutical company focused on the development and commercialization of its investigational drug candidate, veverimer, a non-absorbed, orally-administered polymer designed to slow chronic ...

Tricida, Inc. (TCDA) Q3 2021 Results Conference Call November 08, 2021 04:30 PM ET Company Participants Jackie Cossmon - SVP, IR & Communications Gerrit Klaerner - Founder, CEO & President Geoff Parker - COO, CFO Conference Call Participants Daniel Wolle - JPMorgan Joseph Stringer - N...

Tricida (NASDAQ:TCDA): Q3 GAAP EPS of -$0.79 misses by $0.10. As of September 30, 2021, cash, cash equivalents and investments were $146.8 million. Tricida believes it has financial resources to fund its planned operations through 2022. Press Release For further details see: Tricida EPS...

SOUTH SAN FRANCISCO, Calif., Nov. 08, 2021 (GLOBE NEWSWIRE) -- Tricida, Inc. (Nasdaq: TCDA), a pharmaceutical company focused on the development and commercialization of its investigational drug candidate, veverimer, a non-absorbed, orally-administered polymer designed to slow chronic ...

SOUTH SAN FRANCISCO, Calif., Nov. 02, 2021 (GLOBE NEWSWIRE) -- Tricida, Inc. (Nasdaq: TCDA) today announced that it will report its third quarter 2021 financial results after the close of market on Monday, November 8, 2021. Tricida will host a conference call and webcast at 4:30 pm Eas...

SOUTH SAN FRANCISCO, Calif., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Tricida, Inc. (Nasdaq: TCDA) today announced that it will present at the H.C. Wainwright 23rd Annual Global Investment Conference. Tricida will provide a company overview, business update and progress on the company’...

Tricida, Inc. (TCDA) Q2 2021 Results Conference Call August 09, 2021 04:30 PM ET Company Participants Jackie Cossmon - SVP, IR and Communications Gerrit Klaerner - Founder, CEO and President Geoff Parker - COO and CFO Conference Call Participants Graig Suvannavejh - Goldman Sachs Presentation...

SOUTH SAN FRANCISCO, Calif., Aug. 09, 2021 (GLOBE NEWSWIRE) -- Tricida, Inc. (Nasdaq: TCDA), a pharmaceutical company focused on the development and commercialization of its investigational drug candidate, veverimer, a non-absorbed, orally-administered polymer designed to slow chronic ...